OmniAb Results Presentation Deck

Active Partners Q2 2023: 74 ACTIVE PARTNERS Number of Active Partners 80 70 60 50 40 30 20 10 0 2016 2017 2018 2019 2020 2021 2022 6/30/2023 ● 4 new license agreements signed in Q2 - New platform license agreements with Merck & Co. Inc., Neurocrine Biosciences Inc., Stanford University, and Seattle Children's Hospital Strong annual growth in Active Partners continues, net of attrition Represents the unique number of partners that have an active program or have executed a license agreement in advance of initiating an active program. 6 OmniAb

View entire presentation